EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Preparation of Co-Amorphous System Formulation of Poorly Aqueous Soluble API’s for Suitable Acidic & Basic Drug for Oral Drug Delivery

Roshan Gyawali, S. Rajarajan, Yuvraj Regmi, Sachin Aryal

Dinkum Journal of Medical Innovations · 2024

DOI: 10.71017/djmi.3.06.d-0289 ↗
AbstractBibliografische Angaben

Abstract

The oral route of drug administration is one of the most preferred routes of administration because of higher patient compliance, less expensive manufacturing costs and ease of administration. Drug substances having low aqueous solubility are becoming extensively widespread. The limited aqueous solubility of drugs presents a major challenge during development of dosage form results in poor absorption after oral route administration, for a drug become orally bioavailable, it has to dissolve in GI fluids, especially for drugs belonging to BCS class II & IV. This study described the preparation of co-amorphous system formulation of poorly aqueous soluble API’s for suitable acidic & basic drug for oral drug delivery. Co-amorphous solid dispersion were prepared by dry milling technique with ball milling for 60 min to 120 min by taking 1:1M and 1:3M ratio of drug and coformer and evaluated for the particle size distribution, in-vitro drug release and drug content. Full factorial design was used to get the optimized formula using milling time and drug coformer ratio as variables and particle size distribution, in-vitro drug release and drug content as a responses. The results determined that the production yields for co-amorphous formulations were found to be in the range of 88-92%. The production yields for co-amorphous formulations were found to be in between 88-92% and the production yield for the optimized formulation was found to be 92%. The result concludes that drug and coformer used in formulations were found compatible with each other. Co-amorphous formulations were prepared by ball milling technique at a constant speed for 60 min and 120 min by taking 1:1 M and 1:3 M drug coformer ratio was most suitable.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →